Ms. Natalia Gherman is Assistant Secretary-General (ASG) and Executive Director of the Counter-Terrorism Committee Executive Directorate (CTED).

The Security Council, the Counter-Terrorism Committee, and the Committee’s Executive Directorate (CTED) have actively promoted the integration of the agendas on Women, Peace and Security (WPS...

Chronic thromboembolic pulmonary hypertension (CTEPH) and chronic thromboembolic pulmonary vascular disease (CTED) are rare manifestations of venous thromboembolism. Presumably, CTEPH and CTED are variants of the same pathophysiological mechanism. CTEPH and CTED can be near-cured by pulmonary endart …

The main purpose of this Guide is to assess the key challenges related to detention of persons when countering terrorism and to provide Member States with legal and practical guidance to assist ...

2023年9月1日 · Purpose of review: Chronic thromboembolic disease (CTED) is distinct from chronic thromboembolic pulmonary hypertension (CTEPH) and is defined by dyspnea on exertion after acute pulmonary embolism with the presence of residual perfusion defects and absence of resting pulmonary hypertension.

CTED was established also with the aim of facilitating technical assistance to countries, as well as promoting closer cooperation and coordination both within the UN system of organizations and among regional and intergovernmental bodies.

2021年12月30日 · The Security Council, acting through its written silence procedure today, renewed the mandate of the Counter-Terrorism Committee Executive Directorate (CTED), the expert body that supports the...

The Counter-Terrorism Committee Executive Directorate (CTED) was established by UN Security Council Resolution 1535 (2004) as an expert body to support the Security Council’s Counter-Terrorism Committee (CTC).

2021年12月31日 · The UN Security Council on Thursday unanimously adopted Resolution 2617, renewing the mandate of the Counter-Terrorism Executive Directorate (CTED) for another four years, until Dec 31, 2025.

2024年6月13日 · 慢性血栓栓塞性疾病（CTED）是急性肺栓塞（PE）患者在接受标准抗凝治疗3或6个月后仍可能发生的一种并发症。 尽管这种情况并不罕见，但目前尚无有效的评分模型来预测CTED的发生。